Has Thomas Simopoulos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $180,912 in general payments to Thomas Simopoulos, MD across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Simopoulos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Simopoulos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Simopoulos, MD

Pain Medicine · Boston, MANPI 1295774289

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $119,471 of the $180,912 with a category attached, or 66.0%. 13 manufacturers reported payments, led by Spectra Medical Devices, Inc. at 45.9% of the total. Reporting peaked in 2021 at $58,123 and has fallen 92.9% since, to $4,131 in 2025. Among pain medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$180,912in general payments, 2019–2025

Across 142 payments — averaging $1274.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Spectra Medical Devices, Inc.$83K
Nevro Corp.$57K
Spectra Medical Devices, LLC$25K
Boston Scientific$13K
Abbott$959
Pacira Pharmaceuticals Incorporated$713
plus $2K from 7 others

What the payments were for

Consulting fees$119,47166%
Speaking & faculty fees$47,23826%
Travel & lodging$6,9724%
Food & beverage$7,2324%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Spectra Medical Devices, Inc.	3	$83,000
Nevro Corp.	73	$56,936
Spectra Medical Devices, LLC	5	$24,908
Boston Scientific	28	$12,764
Abbott	14	$959
Pacira Pharmaceuticals Incorporated	2	$713
Stimwave Technologies Incorporated	3	$531
Biotronik NRO, Inc.	5	$368
Globus Medical	4	$284
Curonix LLC	2	$240
Nalu Medical, Inc.	1	$112
Vertos Medical, Inc.	1	$76
Medtronic	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza Spinal Cord Stimulation System$29,609
Omnia$19,351
Senza$7,018
SPECTRA WAVEWRITER$4,251
GENERAL PAIN MANAGEMENT$3,413
WAVEWRITER ALPHA$3,400
GENERAL - THERAPIES$850
EXPAREL$713
Prospera$316
Proclaim Family of SCS IPGs$237
ETERNA$194
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$142
WaveWriter Alpha Prime 16$138
PROCLAIM$128
Nalu Neurostimulation System$112

How this compares

$180,912 in reported general payments places this provider in the 95th percentile of 137 pain medicine providers in Massachusetts.

See all pain medicine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$102,345

Medicare patients

332

Services billed

892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BelbucaBuprenorphine Hcl	15	$8,798
Pregabalin	89	$2,895
Gabapentin	64	$855
Oxycodone Hcl	38	$837
Naloxone Hcl	12	$740
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	32	$622
Tizanidine Hcl	35	$511
Morphine Sulfate	20	$510
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	35	$505
Morphine Sulfate ErMorphine Sulfate	12	$364
Methadone Hcl	18	$348
Baclofen	13	$158
Tramadol Hcl	22	$128
Cyclobenzaprine Hcl	24	$118
Diazepam	13	$37

Paid to pharmacies, not to this prescriber.

Other pain medicine in Boston

Arti OriBoston$62K
Christine SangBoston$56K
Eduard VaynbergBoston$32K
David HaoBoston$16K
Erika YihBoston$8K
Samuel AngBoston$7K
Kevin VuBoston$6K
Brenda LeeBoston$6K
Steven MachBoston$5K
Rupeng LiBoston$4K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →